It was reported that during use with a revaclear 400, specified as "middle" of treatment, a rupture of one end of the dialyzer was observed.It was further reported the patient experienced blood loss (amount not reported) and treatment time was extended.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
|
Additional information added to h3,h6 and h10 h10: the actual device was not returned for evaluation; however, a photograph of the sample was provided.Visual inspection observed blood outside of the dialyzer, on the floor which appeared to have come from the header cap, which was observed to have been taken off.The reported condition was verified.The cause could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|